Select a Region North America


Rich Heddens

SVP, Payer Strategy & Execution


Brand Plan Development, Commercialization, Complex Therapies, Field Sales & Reimbursement, Managed Markets, Market Access, Payers, Pricing, Reimbursement & Market Access, Rare Disease, Stakeholder Engagement & Promotion (Patients, Payers, Providers)

Rich Heddens, Senior Vice President of Payer Strategy & Execution, is helping EVERSANA’s partners drive life-changing therapies to market and into the hands of patients. As a leader in market access, sales and marketing for pharma and biotech, Rich has 20 years of experience in business development and client management. Through his career at companies, such as MedImmune, Novartis, inVentiv Health and Syneos Health, he specializes in managed markets, field sales, account management and national account management, reimbursement practices, market access and public health. He las led more than 20 pharma and biopharma product launches across multiple disease and treatment areas.

Rich earned his bachelor’s degree in business from the University of Wisconsin – La Crosse.

Articles by Rich Heddens

Payer Oncology Access Management in 2022

Payers balance the severity of disease with the need to control high-dollar utilization. As pharmacy spend continues to rise, payers are seeking ways to manage costs in the highest cost therapeutic areas, including oncology. While there is appetite to manage access for both oral and office-administered oncology agents, payers struggle with which tactics to implement without sacrificing patient […]

Accelerate Patient Therapy Adoption by Eliminating Obstructive Pain Points and Waiting Games

Acquiring all the necessary information to initiate patients’ treatment can sometimes feel like a bad game of Telephone to HCPs and their staff. Missing or inaccurate details that can require multiple phone calls, emails or faxes to various individuals can eat up staffs’ time and resources and prolong patients’ adoption of therapy.  EVERSANA’s Field Reimbursement Managers […]

Elevate Your Brand to New Heights by Utilizing National Account Managers’ Singular Skills, Resources and Experience in an Ever-changing Marketplace

Launching new therapies is a vast undertaking for any pharmaceutical company. Setting up a product for success requires a great deal of expense, research, strategic planning and effective collaboration, just to name a few essential elements. EVERSANA’s National Account Managers (NAMs) serve as fully integrated partners to manufacturers, invested in the success of their products and in […]

Connectivity Between Field Reimbursement Managers and Patient Services: The Missing Link to Efficiency

EVERSANA’s Rich Heddens, Senior Vice President, Payer Strategy & Execution, and Matthew Baniak, Vice President, Client Delivery & Excellence, discuss the importance of connectivity between Field Reimbursement Managers (FRMs) and Patient Services.   Disparate information, antiquated systems and a disconnect between the two service areas often translate to pain points experienced by patients and providers. EVERSANA’s […]

Innovative Payer Strategies Demand Innovative NAM Strategies

EVERSANA’s Rich Heddens, Senior Vice President, Payer Strategy & Execution, and Dino Tsamparlis, Vice President, Market Access, discuss how innovative payer strategies call for innovative National Account Manager (NAM) strategies.  The industry is facing unique challenges that did not exist prior to COVID-19. Payer mixes have changed substantially in the U.S., subsequently altering the economics […]

EVERSANA’s Integrated Operations, Data-Driven Solutions and Digital Expertise Solve Key Challenges in Market Access and Field Deployment

Pharmaceutical manufacturers relying on the standard model for executing market access and field deployment strategies utilize resources inefficiently and redundantly. By integrating actions across operations, manufacturers can right size company resources, ensure affordability and increase speed to therapy. Four key industry-wide challenges have been identified in market access and field deployment. EVERSANA’s next generation model […]

Informing NAMs Payer Strategies and Improving Contracts With Integrated Commercial Services

Pharmaceutical manufacturers rely on national account managers (NAMs) to build relationships, negotiate contracts and get their products in front of payers and pharmacy benefit managers who will clear the way for patient treatment coverage. Challenges Facing NAMs Typically, NAMs rely on the customer or the health plan to direct contracting strategies and product expectations, and […]

Revolutionizing FRMs With Data Connectivity and Commercial Services Integration

FRMs, sometimes referred to as field reimbursement specialists or patient experience specialists, are the key drivers in patient pre-authorization and billing and coding processes, and play a vital role in the prescription and adoption of specialty drugs. While field reps focus on selling, FRMs focus solely on supporting healthcare provider (HCP) offices and helping office […]

Interested in scheduling a meeting or speaking event?

Contact Us